Cargando…

Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer

BACKGROUND: Tissue kallikrein-related peptidases 4, 5, 6 and 7 (KLK4–7) strongly increase the malignancy of ovarian cancer cells. Deciphering their downstream effectors, we aimed at finding new potential prognostic biomarkers and treatment targets for ovarian cancer patients. KLK4–7-transfected (OV-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Ping, Magdolen, Viktor, Seidl, Christof, Dorn, Julia, Drecoll, Enken, Kotzsch, Matthias, Yang, Feng, Schmitt, Manfred, Schilling, Oliver, Rockstroh, Anja, Clements, Judith Ann, Loessner, Daniela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6189062/ https://www.ncbi.nlm.nih.gov/pubmed/30287916 http://dx.doi.org/10.1038/s41416-018-0260-1

Ejemplares similares

Quantitative assessment and clinical relevance of kallikrein-related peptidase 5 mRNA expression in advanced high-grade serous ovarian cancer
por: Gong, Weiwei, et al.
Publicado: (2019)

Characterization of kallikrein-related peptidase 4 (KLK4) mRNA expression in tumor tissue of advanced high-grade serous ovarian cancer patients
por: Gong, Weiwei, et al.
Publicado: (2019)

Clinical relevance of kallikrein-related peptidase 9, 10, 11, and 15 mRNA expression in advanced high-grade serous ovarian cancer
por: Geng, Xiaocong, et al.
Publicado: (2017)

Secretome and degradome profiling shows that Kallikrein‐related peptidases 4, 5, 6, and 7 induce TGFβ‐1 signaling in ovarian cancer cells
por: Shahinian, Hasmik, et al.
Publicado: (2013)

Kallikrein-Related Peptidase 6 Is Associated with the Tumour Microenvironment of Pancreatic Ductal Adenocarcinoma
por: Candido, Juliana B., et al.
Publicado: (2021)

Prognostic value of kallikrein-related peptidase 7 (KLK7) mRNA expression in advanced high-grade serous ovarian cancer
por: Gong, Weiwei, et al.
Publicado: (2020)

Metastasis of ovarian cancer is mediated by kallikrein related peptidases
por: Dong, Ying, et al.
Publicado: (2013)

Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs)
por: Goettig, Peter, et al.
Publicado: (2010)

Emerging clinical importance of the cancer biomarkers kallikrein-related peptidases (KLK) in female and male reproductive organ malignancies
por: Schmitt, Manfred, et al.
Publicado: (2013)

Kallikrein-Related Peptidases in Prostate Cancer: From Molecular Function to Clinical Application
por: Fuhrman-Luck, Ruth A., et al.
Publicado: (2014)

Structural basis for the Zn(2+) inhibition of the zymogen-like kallikrein-related peptidase 10
por: Debela, Mekdes, et al.
Publicado: (2016)

A Single Glycan at the 99-Loop of Human Kallikrein-related Peptidase 2 Regulates Activation and Enzymatic Activity
por: Skala, Wolfgang, et al.
Publicado: (2016)

Prognostic value of kallikrein-related peptidase 12 (KLK12) mRNA expression in triple-negative breast cancer patients
por: Gong, Weiwei, et al.
Publicado: (2020)

Paclitaxel Resistance and Multicellular Spheroid Formation Are Induced by Kallikrein-Related Peptidase 4 in Serous Ovarian Cancer Cells in an Ascites Mimicking Microenvironment
por: Dong, Ying, et al.
Publicado: (2013)

Structure-Function Analyses of Human Kallikrein-related Peptidase 2 Establish the 99-Loop as Master Regulator of Activity
por: Skala, Wolfgang, et al.
Publicado: (2014)

Aberrant expression of kallikrein‐related peptidase 7 is correlated with human melanoma aggressiveness by stimulating cell migration and invasion
por: Delaunay, Tiphaine, et al.
Publicado: (2017)

The molecular function of kallikrein‐related peptidase 14 demonstrates a key modulatory role in advanced prostate cancer
por: Kryza, Thomas, et al.
Publicado: (2019)

Kallikrein-related peptidases 6 and 10 are elevated in cerebrospinal fluid of patients with Alzheimer’s disease and associated with CSF-TAU and FDG-PET
por: Goldhardt, Oliver, et al.
Publicado: (2019)

Rab31-dependent regulation of transforming growth factor ß expression in breast cancer cells
por: Soelch, Susanne, et al.
Publicado: (2021)

Involvement of Kallikrein-Related Peptidases in Normal and Pathologic Processes
por: Stefanini, Ana Carolina B., et al.
Publicado: (2015)

Involvement of Kallikrein-Related Peptidases in Nervous System Disorders
por: Mella, Cinthia, et al.
Publicado: (2020)

Kallikrein‐related peptidase 4 induces cancer‐associated fibroblast features in prostate‐derived stromal cells
por: Kryza, Thomas, et al.
Publicado: (2017)

Mass spectrometry-based determination of Kallikrein-related peptidase 7 (KLK7) cleavage preferences and subsite dependency
por: Silva, Lakmali Munasinghage, et al.
Publicado: (2017)

Expression of kallikrein-related peptidase 7 is decreased in prostate cancer
por: Zhang, Chong-Yu, et al.
Publicado: (2015)

Expression and function of the Kallikrein-related peptidase 6 in the human melanoma microenvironment
por: Krenzer, Stefanie, et al.
Publicado: (2011)

The use of kallikrein-related peptidases as adjuvant prognostic markers in colorectal cancer
por: Talieri, M, et al.
Publicado: (2009)

Kallikrein-related peptidase 8 is expressed in myocardium and induces cardiac hypertrophy
por: Cao, Buqing, et al.
Publicado: (2016)

Radioimmunotherapy of prostate cancer targeting human kallikrein-related peptidase 2
por: Vilhelmsson Timmermand, O., et al.
Publicado: (2016)

Erratum: Kallikrein-related peptidase 8 is expressed in myocardium and induces cardiac hypertrophy
por: Cao, Buqing, et al.
Publicado: (2016)

Kallikrein-related peptidase 7 is a potential target for the treatment of pancreatic cancer
por: Du, Jian Ping, et al.
Publicado: (2018)

Human Tissue Kallikreins-Related Peptidases Are Targets for the Treatment of Skin Desquamation Diseases
por: Zani, Marcelo B., et al.
Publicado: (2022)

High kallikrein-related peptidase 6 in non-small cell lung cancer cells: an indicator of tumour proliferation and poor prognosis
por: Nathalie, Heuzé-Vourc’h, et al.
Publicado: (2009)

Doxycycline Indirectly Inhibits Proteolytic Activation of Tryptic Kallikrein-Related Peptidases and Activation of Cathelicidin
por: Kanada, Kimberly N., et al.
Publicado: (2012)

A novel role of kallikrein-related peptidase 8 in the pathogenesis of diabetic cardiac fibrosis
por: Du, Jian-Kui, et al.
Publicado: (2021)

Kallikrein-related peptidase 13 expression and clinicopathological features in lung squamous cell carcinoma
por: Sumiya, Ryusuke, et al.
Publicado: (2023)

Rab31 expression levels modulate tumor-relevant characteristics of breast cancer cells
por: Grismayer, Bettina, et al.
Publicado: (2012)

Loss of kallikrein‐related peptidase 7 exacerbates amyloid pathology in Alzheimer's disease model mice
por: Kidana, Kiwami, et al.
Publicado: (2018)

Human kallikrein-related peptidase 12 stimulates endothelial cell migration by remodeling the fibronectin matrix
por: Kryza, T., et al.
Publicado: (2018)

Biomarker implication of kallikrein-related peptidases as prognostic tissue substrates of poor survival in colorectal cancer
por: Peng, Qiliang, et al.
Publicado: (2020)

Could Kallikrein-Related Serine Peptidase 3 Be an Early Biomarker of Environmental Exposure in Young Women?
por: Raimondo, Salvatore, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qbcoetnsbpd5vsi51kuhk2rotg